Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle.

Khachatoorian R, Arumugaswami V, Raychaudhuri S, Yeh GK, Maloney EM, Wang J, Dasgupta A, French SW.

Virology. 2012 Nov 25;433(2):346-55. doi: 10.1016/j.virol.2012.08.029. Epub 2012 Sep 11.

PMID:
22975673
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents.

Buckwold VE, Beer BE, Donis RO.

Antiviral Res. 2003 Sep;60(1):1-15. Review.

PMID:
14516916
[PubMed - indexed for MEDLINE]
3.

The hepatitis C virus life cycle as a target for new antiviral therapies.

Pawlotsky JM, Chevaliez S, McHutchison JG.

Gastroenterology. 2007 May;132(5):1979-98. Review.

PMID:
17484890
[PubMed - indexed for MEDLINE]
4.

[Involvement of nonstructural protein 5A and lipids on production of hepatitis C virus particles].

Suzuki T, Masaki T, Aizaki H.

Uirusu. 2008 Dec;58(2):199-205. Review. Japanese.

PMID:
19374198
[PubMed - indexed for MEDLINE]
Free Article
5.

Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy.

Lee C.

Arch Pharm Res. 2011 Sep;34(9):1403-7. doi: 10.1007/s12272-011-0921-6. Review.

PMID:
21975800
[PubMed - indexed for MEDLINE]
6.

Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein.

Belda O, Targett-Adams P.

Virus Res. 2012 Dec;170(1-2):1-14. doi: 10.1016/j.virusres.2012.09.007. Epub 2012 Sep 23. Review.

PMID:
23009750
[PubMed - indexed for MEDLINE]
7.

Hepatitis C viral protein translation: mechanisms and implications in developing antivirals.

Hoffman B, Liu Q.

Liver Int. 2011 Nov;31(10):1449-67. doi: 10.1111/j.1478-3231.2011.02543.x. Epub 2011 May 5. Review.

PMID:
21745290
[PubMed - indexed for MEDLINE]
8.

Oligonucleotide-based strategies to inhibit human hepatitis C virus.

Martinand-Mari C, Lebleu B, Robbins I.

Oligonucleotides. 2003;13(6):539-48. Review.

PMID:
15025918
[PubMed - indexed for MEDLINE]
9.

Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.

Gale MJ Jr, Korth MJ, Katze MG.

Clin Diagn Virol. 1998 Jul 15;10(2-3):157-62. Review.

PMID:
9741641
[PubMed - indexed for MEDLINE]
10.

Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.

Blight KJ, Kolykhalov AA, Reed KE, Agapov EV, Rice CM.

Antivir Ther. 1998;3(Suppl 3):71-81. Review.

PMID:
10726057
[PubMed - indexed for MEDLINE]
11.

New insights into structure and replication of the hepatitis C virus and clinical implications.

Poenisch M, Bartenschlager R.

Semin Liver Dis. 2010 Nov;30(4):333-47. doi: 10.1055/s-0030-1267535. Epub 2010 Oct 19. Review.

PMID:
20960374
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk